Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11451880 | PMC |
| http://dx.doi.org/10.1513/AnnalsATS.202407-706ED | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Global, regional, and national burden of childhood cardiovascular disease: trends from 1990 to 2021.
Front Pediatr
December 2024
Department of Anesthesiology, Qingdao Women and Children's Hospital, School of Medicine, Shandong University, Jinan, China.
Background: Childhood cardiovascular disease (CVD) is an emerging public health concern, with rising incidence linked to obesity and diabetes. Despite advancements in care, significant disparities persist across regions and socioeconomic groups. This study analyzed the global, regional, and national burden of childhood CVD from 1990 to 2021.
View Article and Find Full Text PDFManagement of Orofacial Infantile Haemangioma: A Case Report.
Case Rep Dent
December 2024
Department of Paediatric Dentistry, Selayang Hospital (Ministry of Health), Batu Caves, Selangor, Malaysia.
Infantile haemangioma (IH) is the most common childhood tumour, often developing in the head and neck region. It may cause disfigurement, functional impairment, or tooth developmental issues when it is present in the oral cavity. We report a case of a 2-month-old boy referred to the paediatric dentistry team with a segmental IH involving the left periorbital, cheek, and hard palate.
View Article and Find Full Text PDFHealth-related Quality of Life in children and adolescents treated for acute lymphoblastic leukaemia (ALL), compared with healthy peers: a longitudinal study of early survivorship.
J Cancer Surviv
December 2024
Children's Cancer Centre, The Royal Children's Hospital, Melbourne, VIC, Australia.
Purpose: Survival for childhood Acute Lymphoblastic Leukaemia (ALL) has surpassed 90%, making quality of survival an important endpoint in treatment outcomes. This study examined health-related quality of life (HRQoL) trajectories in early survivorship for patients post-ALL treatment compared with a matched group of healthy peers, and explored the association of individual factors (age, sex) and treatment intensity with HRQoL outcomes.
Methods: Eighty-three paediatric patients aged 4-16 years who recently completed treatment for ALL were recruited to the study, alongside 53 age- and sex-matched healthy children.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!